Waystar, Inc.
Classification
Public
About
About
Waystar, Inc. is a provider of healthcare payments software, dedicated to simplifying and improving the healthcare revenue cycle for providers, patients, and payers. Established from the merger of several healthcare technology companies, Waystar leverages advanced algorithms and AI to automate and enhance payment-related workflow tasks. The company serves a diverse client base that includes physician practices, clinics, surgical centers, laboratories, and large hospitals. Product Breakdown Waystar offers a comprehensive suite of revenue cycle management solutions. Their platform includes tools for claim management, which automates the submission, monitoring, and follow-up of claims to ensure accurate and timely reimbursement. The payment management module focuses on optimizing the reimbursement process from payers and patients, including electronic remittance advice and payment posting. Denial prevention and recovery tools help identify and address reasons for claim denials, improving overall revenue capture. The platform also features analytics and reporting capabilities, providing actionable insights to enhance operational efficiency and financial performance. Additional services include eligibility verification, patient estimation, charity screening, and coverage detection, all designed to streamline administrative tasks and improve patient financial interactions
Financials
Revenue & Profit
Valuation
Ratios
People
Deals
M&A2024-03-15Completed
Investor Sponsors NorthBridge PE | Stake Tags 100% |
Deal Amount $120M | Is PE deal Yes |
Target Company Valuation $1.20 MM | Is deal PE backed Yes |
Techniques Acquisition of Assets, Taken Private | Total Acquired 100% |
Investor Sponsors
Deal Amount
$120M
Target Company Valuation
$1.20 MM
Techniques
Acquisition of Assets, Taken Private
Stake Tags
100%
Is PE deal
Yes
Is deal PE backed
Yes
Total Acquired
100%
Secondary Transaction2023-09-01Canceled
Investor Sponsors -- | Stake Tags Majority |
Deal Amount Undisclosed | Is PE deal No |
Target Company Valuation -- | Is deal PE backed Yes |
Techniques Secondary Sale, Management Buy-out (MBO) | Total Acquired 65% |
Investor Sponsors
--
Deal Amount
Undisclosed
Target Company Valuation
NaN
Techniques
Secondary Sale, Management Buy-out (MBO)
Stake Tags
Majority
Is PE deal
No
Is deal PE backed
Yes
Total Acquired
65%
Funding
Keywords
Keywords
Classified
Private